Sedative drug modulates T-cell and lymphocyte function-associated antigen-1 function

Anesthesia and Analgesia

Volumn 112, Issue 4, 2011, Pages 830-838

  Yuki, Koichi ^a,c   Soriano, Sulpicio G ^a,c   Shimaoka, Motomu ^a,b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Immune Disease Institute   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MIDAZOLAM; PROPOFOL;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; DRUG EFFECT; HUMAN; HUMAN CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE;

EID: 79953220429     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e31820dcabb     Document Type: Article

References (53)

1. Sanders RD, Hussell T, Maze M. Sedation & immunomodulation. Crit Care Clin 2009;25:551-70
2. Thacker MA, Clark AK, Marchand F, McMahon SB. Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesth Analg 2007;105:838-47 (Pubitemid 47300869)
3. Abram CL, Lowell CA. The ins and outs of leukocyte integrin signaling. Annu Rev Immunol 2009;27:339-62
4. Demotz S, Grey HM, Sette A. The minimal number of lass II MHC-antigen complexes needed for T cell activation. Science 1990;249:1028-30
5. Harding CV, Unanue ER. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature 1990;346:574-6
6. Wang Y, Li D, Nurieva R, Yang J, Sen M, Carreno R, Lu S, Mcintyre BW, Molldrem JJ, Legge GB, Ma Q. LFA-1 affinity regulation is necessary for the activation and proliferation of naive T cells. J Biol Chem 2009;284:12645-53
7. Bachmann MF, Oxenius A. Interleukin 2: from immunostimulation to immunoregulation and back again. EMBO Rep 2007;8:1142-8 (Pubitemid 350201732)
8. Ding ZM, Babensee JE, Simon SI, Lu H, Perrard JL, Bullard DC, Dai XY, Bromley SK, Dustin ML, Entman ML, Smith CW, Ballantyne CM. Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration. J Immunol 1999;163:5029-38 (Pubitemid 29501271)
9. Helmy SA, Al-Attiyah RJ. The immunomodulatory effects of prolonged intravenous infusion of propofol versus midazolam in critically ill surgical patients. Anaesthesia 2001;56:4-8 (Pubitemid 32111865)
10. Helmy SA, Wahby MA, El-Nawaway M. The effect of anaesthesia and surgery on plasma cytokine production. Anaesthesia 1999;54:733-8 (Pubitemid 29389312)
11. Helmy SA, Al-Attiyah RJ. The effect of halothane and isoflurane on plasma cytokine levels. Anaesthesia 2000;55:904-10
12. Shimaoka M, Takagi J, Springer TA. Conformational regulation of integrin structure and function. Annu Rev Biophys Struct 2002;31:485-516 (Pubitemid 34666842)
13. Shimaoka M, Springer TA. Therapeutic antagonists and conformational regulation of integrin function. Nat Rev Drug Discov 2003;2:703-16 (Pubitemid 37361786)
14. Springer TA, Wang JH. The three-dimensional structure of integrins and their ligands, and conformational regulation of cell adhesion. Adv Protein Chem 2004;68:29-63 (Pubitemid 41184478)
15. Kallen J, Welzenbach K, Ramage P, Geyl D, Kriwacki R, Legge G, Cottens S, Weitz-Schmidt G, Hommel U. Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain. J Mol Biol 1999;292:1-9 (Pubitemid 29425648)
16. Yuki K, Astrof NS, Bracken C, Yoo R, Silkworth W, Soriano SG, Shimaoka M. The volatile anesthetic isoflurane perturbs conformational activation of integrin LFA-1 by binding to the allosteric regulatory cavity. FASEB J 2008;22:4109-16
17. Zhang H, Astrof NS, Liu JH, Wang JH, Shimaoka M. Crystal structure of isoflurane bound to integrin LFA-1 supports a unified mechanism of volatile anesthetic action in the immune and central nervous systems. FASEB J 2009;23:2735-40
18. Yuki K, Astrof NS, Bracken C, Soriano SG, Shimaoka M. Sevoflurane binds and allosterically blocks integrin lymphocyte function-associated antigen-1. Anesthesiology 2010;113: 600-9
19. Sanchez-Madrid F, Krensky AM, Ware CF, Robbins E, Strominger JL, Burakoff SJ, Springer TA. Three distinct antigens associated with human T lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. Proc Natl Acad Sci USA 1982;79: 7489-93 (Pubitemid 13179132)
20. Petruzzelli L, Maduzia L, Springer TA. Activation of lymphocyte function-associated molecule-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) mimicked by an antibody directed against CD18. J Immunol 1995;155:854-66
21. Kelly TA, Jeanfavre DD, McNeil DW, Woska JR Jr, Reilly PL, Mainolfi EA, Kishimoto KM, Nabozny GH, Zinter R, Bormann BJ, Rothlein R. Cutting edge: a small molecule antagonist of LFA-1-mediated cell adhesion. J Immunol 1999;163:5173-7
22. Shimaoka M, Salas A, Yang W, Weiz-Schmidt G, Springer TA. Small molecule integrin antagonists that bind to the β2 subunit I-like domain and activate signals in one direction and block them in another. Immunity 2003;19:391-402 (Pubitemid 37153415)
23. Lu C, Shimaoka M, Ferzly M, Oxvig C, Takagi J, Springer TA. An isolated, surface-expressed I domain of the integrin aLb2 is sufficient for strong adhesive function when locked in the open conformation with a disulfide. Proc Natl Acad Sci USA 2001;98:2387-92 (Pubitemid 32209492)
24. Short TG, Aun CS, Tan P, Wong J, Tam YH, Oh TE. A prospective evaluation of pharmacokinetic model controlled infusion of propofol in paediatric patients. Br J Anaesth 1994;72:302-6 (Pubitemid 24089740)
25. Gepts E, Camu F, Cockshott ID, Douglas EJ. Disposition of propofol administered as constant rate intravenous infusions in humans. Anesth Analg 1987;66:1256-63 (Pubitemid 18024603)
26. Albanese J, Martin C, Lacarelle B, Saux P, Durand A, Gouin F. Pharmacokinetics of long-term propofol infusion used for sedation in ICU patients. Anesthesiology 1990;73:214-7 (Pubitemid 20295277)
27. Kishikawa H, Kobayashi K, Takemori K, Okabe T, Ito K,Sakamoto A. The effects of dexmedetomidine on human neutrophil apoptosis. Biomed Res 2008;29:189-94
28. Nishina K, Akamatsu H, Mikawa K, Shiga M, Maekawa N, Obara H, Niwa Y. The effects of clonidine and dexmedetomidine on human neutrophil functions. Anesth Analg 1999; 88:452-8 (Pubitemid 29070215)
29. Nishina K, Akamatsu H, Mikawa K, Shiga M, Maekawa N, Obara H, Niwa Y. The inhibitory effects of thiopental, midazolam, and ketamine on human neutrophil functions. Anesth Analg 1998;86:159-65 (Pubitemid 28040111)
30. Ho CM, Tarng GW, Su CK. Comparison of effects of propofol and midazolam at sedative concentrations on sympathetic tone generation in the isolated spinal cord of neonatal rats. Acta Anaesthesiol Scand 2007;51:708-13
31. Lu C, Shimaoka M, Salas A, Springer TA. The binding sites for competitive antagonistic, allosteric antagonistic, and agonistic antibodies to the I domain of integrin LFA-1. J Immunol 2004;173:3972-8 (Pubitemid 39280761)
32. Bishara A, Malka R, Brautbar C, Barak V, Cohen I, Kedar E. Cytokine production in human mixed leukocyte reactions performed in serum-free media. J Immunol Methods 1998;215:187-90 (Pubitemid 28404872)
33. McCabe SM, Riddle L, Nakamura GR, Prashad H, Mehta A, Berman PW, Jardieu P. sICAM-1 enhances cytokine production stimulated by alloantigen. Cell Immunol 1993;150: 364-75 (Pubitemid 23290340)
34. Gadek TR, Burdick DJ, McDowell RS, Stanley MS, Marsters JC Jr, Paris KJ, Oare DA, Reynolds ME, Ladner C, Zioncheck KA, Lee WP, Gribling P, Dennis MS, Skelton NJ, Tumas DB, Clark KR, Keating SM, Beresini MH, Tilley JW, Presta LG, Bodary SC. Generation of an LFA-1 antagonist by the transfer of the ICAM-1 immunoregulatory epitope to a small molecule. Science 2002;295:1086-9 (Pubitemid 34132241)
35. Kinashi T. Intracellular signaling controlling integrin activation in lymphocytes. Nat Rev Immunol 2005;5:546-59 (Pubitemid 40961332)
36. van Kooyk Y, van Vliet SJ, Figdor CG. The actin cytoskeleton regulates LFA-1 ligand binding through avidity rather than affinity changes. J Biol Chem 1999;274:26869-77
37. Oscarsson A, Massoumi R, Sjolander A, Eintrei C. Reorganization of actin in neurons after propofol exposure. Acta Anaesthesiol Scand 2001;45:1215-20 (Pubitemid 33063405)
38. Garib V, Lang K, Niggemann B, Zanker KS, Brandt L, Dittmar T. Propofol-induced calcium signaling and actin reorganization within breast carcinoma cells. Eur J Anaesthesiol 2005;22:609-15 (Pubitemid 41097864)
39. Mammoto T, Mukai M, Mammoto A, Yamanaka Y, Hayashi Y, Mashimo T, Kishi Y, Nakamura H. Intravenous anesthetic, propofol inhibits invasion of cancer cells. Cancer Lett 2002;184:165-70 (Pubitemid 34804502)
40. Inada T, Taniuchi S, Shingu K, Kobayasgi Y, Fujisawa J, Nakao S. Propofol depressed neutrophil hydrogen peroxide production more than midazolam, whereas adhesion molecule expression was minimally affected by both anesthetics in rats with abdominal sepsis. Anesth Analg 2001;92:437-41 (Pubitemid 32127633)
41. Abraham C, Miller J. Molecular mechanisms of IL-2 gene regulation following costimulation through LFA-1. J Immunol 2001;167:193-201
42. Van Seventer GA, Shimizu Y, Horgan KJ, Horgan KJ, Shaw S. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol 1990;144:4579-86 (Pubitemid 20224088)
43. Shimizu Y. LFA-1: more than just T cell velcro. Nat Immunol 2003;4:1052-4 (Pubitemid 37428025)
44. Kane LP, Andres PG, Howland KC, Abbas AK, Weiss . Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not TH2 cytokines. Nat Immunol 2001;2:37-44 (Pubitemid 33704951)
45. Nagata T, Kansha M, Irita K, Takahashi S. Propofol inhibits FMLP-stimulated phosphorylation of p42 mitogen-activated protein kinase and chemotaxis in human neutrophils. Br J Anaesth 2001;86:853-8 (Pubitemid 32514901)
46. Hoyer KK, Dooms H, Barron L, Abbas AK. Interleukin-2 in the development and control of inflammatory disease. Immunol Rev 2008;226:19-28
47. Margolin KA. Interleukin-2 in the treatment of renal cancer. Semin Oncol 2000;27:194-203 (Pubitemid 30205374)
48. Dutcher J. Current status of interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanoma. Oncology (Williston Park) 2002;16:4-10
49. Pahwa S, Morales M. Interleukin-2 therapy in HIV infection. AIDS Patient Care STDS 1998;12:187-97 (Pubitemid 28150908)
50. Oberholzer A, Oberholzer C, Moldawer LL. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 2001;16:83-96 (Pubitemid 33596740)
51. Hotchkiss RS, Nicholson DW. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 2006;6: 813-21
52. Pandharipande PP, Sanders RD, Girard TD, McGrane S, Thompson JL, Shintani AK, Herr DL, Maze M, Ely EW. Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Crit Care 2010;14:R38
53. Cury-Boaventura M, Gorjao R, Martins de Lima T, Soriano F, Curi R. Toxicity of two lipid emulsions on human lymphocytes and neutrophils. Crit Care 2007;11:P408